Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Metastatic Breast Cancer × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 228 Carcinoma, Intraductal, Noninfiltrating 19 Breast Carcinoma In Situ 15 Neoplasm Metastasis 13 Neoplasms 11 Breast Neoplasms, Male 11 Ovarian Neoplasms 8 Inflammatory Breast Neoplasms 6 Glioblastoma 5 Endometrial Neoplasms 4 Central Nervous System Neoplasms 4 Prostatic Neoplasms 3 Obesity 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Breast Cancer Female 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Sleep Wake Disorders 2 Recurrence 2 Multiple Endocrine Neoplasia Type 1 2 Hot Flashes 2 Glioma 2 Fibroadenoma 2 ER+ Breast Cancer 2 Astrocytoma 2 Vitamin D Deficiency 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1

Interventions

vistusertib 1 ribociclib 1 Tamoxifen 1 Letrozole 1 Goserelin 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02278120 2024-03-12

MONALEESA-7

Novartis

Phase 3 Completed

672 enrolled 16 charts 1 FDA

Advanced Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡